These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 8619597)
1. Short-term topical therapy of experimental tinea pedis in guinea pigs with lanoconazole, a new imidazole antimycotic agent. Niwano Y; Tabuchi T; Kanai K; Hamaguchi H; Uchida K; Yamaguchi H Antimicrob Agents Chemother; 1995 Oct; 39(10):2353-5. PubMed ID: 8619597 [TBL] [Abstract][Full Text] [Related]
2. [Therapeutic efficacy of lanoconazole ointment in guinea pig model of tinea pedis, in comparison with that of cream preparations]. Niwano Y; Tabuchi T; Kanai K; Hamaguchi H; Uchida K; Yamaguchi H Jpn J Antibiot; 1994 Sep; 47(9):1192-5. PubMed ID: 7990259 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of lanoconazole, a new imidazole antimycotic agent, for experimental cutaneous candidiasis in guinea pigs. Niwano Y; Seo A; Kanai K; Hamaguchi H; Uchida K; Yamaguchi H Antimicrob Agents Chemother; 1994 Sep; 38(9):2204-6. PubMed ID: 7811048 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo antidermatophyte activities of NND-502, a novel optically active imidazole antimycotic agent. Niwano Y; Kuzuhara N; Kodama H; Yoshida M; Miyazaki T; Yamaguchi H Antimicrob Agents Chemother; 1998 Apr; 42(4):967-70. PubMed ID: 9559824 [TBL] [Abstract][Full Text] [Related]
5. In vivo fungicidal effect of KP-103 in a guinea pig model of interdigital tinea pedis determined by using a new method for removing the antimycotic carryover effect. Tatsumi Y; Yokoo M; Arika T; Yamaguchi H Microbiol Immunol; 2002; 46(7):433-9. PubMed ID: 12222929 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of lanoconazole (Astat) cream in the treatment of hyperkeratotic type tinea pedis. Comparative study of monotherapy and combination therapy with 10% urea ointment (Pastaron). Tanuma H; Tanuma M; Abe M; Kume H Mycoses; 2001; 44(5):181-90. PubMed ID: 11486456 [TBL] [Abstract][Full Text] [Related]
7. Short-term therapy with luliconazole, a novel topical antifungal imidazole, in guinea pig models of tinea corporis and tinea pedis. Koga H; Nanjoh Y; Kaneda H; Yamaguchi H; Tsuboi R Antimicrob Agents Chemother; 2012 Jun; 56(6):3138-43. PubMed ID: 22391525 [TBL] [Abstract][Full Text] [Related]
8. Antifungal activity of the new agent latoconazole in two tinea models. Ohmi T; Konaka S; Uchida M; Yamaguchi H Arzneimittelforschung; 1991 Aug; 41(8):847-51. PubMed ID: 1781809 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of omoconazole nitrate on experimental tinea pedis, an intractable dermatophytosis, in guinea-pigs. Itoyama T; Uchida K; Yamaguchi H; Fujita S J Antimicrob Chemother; 1997 Sep; 40(3):441-4. PubMed ID: 9338501 [TBL] [Abstract][Full Text] [Related]
10. [Therapeutic efficacy of lanoconazole ointment in guinea pig model of tinea corporis, a comparative study with ointment and cream preparations]. Niwano Y; Tabuchi T; Kanai K; Hamaguchi H; Uchida K; Yamaguchi H Jpn J Antibiot; 1995 Jan; 48(1):150-4. PubMed ID: 7699840 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of latoconazole in formulations of clinical use on experimental dermatophytosis in guinea pigs. Oka H; Niwano Y; Ohmi T; Tanaka T; Uchida M; Yamaguchi H Arzneimittelforschung; 1992 Mar; 42(3):345-9. PubMed ID: 1497697 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine. Tatsumi Y; Yokoo M; Senda H; Kakehi K Antimicrob Agents Chemother; 2002 Dec; 46(12):3797-801. PubMed ID: 12435679 [TBL] [Abstract][Full Text] [Related]
13. Achievement of complete mycological cure by topical antifungal agent NND-502 in guinea pig model of tinea pedis. Uchida K; Tanaka T; Yamaguchi H Microbiol Immunol; 2003; 47(2):143-6. PubMed ID: 12680717 [TBL] [Abstract][Full Text] [Related]
14. Development of a new medium useful for the recovery of dermatophytes from clinical specimens by minimizing the carryover effect of antifungal agents. Nakashima T; Nozawa A; Ito T; Majima T; Yamaguchi H Microbiol Immunol; 2002; 46(2):83-8. PubMed ID: 11939582 [TBL] [Abstract][Full Text] [Related]
15. [A study on effectiveness of treatment and prevention of relapse using topical administration of terbinafine in a guinea pig model for tinea pedis]. Uchida K; Kudoh M; Yamaguchi H Jpn J Antibiot; 1994 Oct; 47(10):1407-12. PubMed ID: 7807700 [TBL] [Abstract][Full Text] [Related]
16. Topical treatment with butenafine significantly lowers relapse rate in an interdigital tinea pedis model in guinea pigs. Arika T; Yokoo M; Yamaguchi H Antimicrob Agents Chemother; 1992 Nov; 36(11):2523-5. PubMed ID: 1489197 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of once-daily luliconazole 1% cream in patients ≥12 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind,vehicle-controlled study. Jarratt M; Jones T; Adelglass J; Bucko A; Pollak R; Roman-Miranda A; Olin JT; Swinyer L J Drugs Dermatol; 2014 Jul; 13(7):838-46. PubMed ID: 25007368 [TBL] [Abstract][Full Text] [Related]
18. Comparison of an antifungal agent used alone with an antifungal used with a topical steroid in inflammatory tinea pedis. Elewski BE; Jones T; Zaias N Cutis; 1996 Oct; 58(4):305-7. PubMed ID: 8894432 [TBL] [Abstract][Full Text] [Related]
19. Tinea pedis: clinical experience and efficacy of short treatment. Evans EG Dermatology; 1997; 194 Suppl 1():3-6. PubMed ID: 9154392 [TBL] [Abstract][Full Text] [Related]
20. Once-daily luliconazole cream 1% for the treatment of interdigital tinea pedis. Gold MH; Olin JT Expert Rev Anti Infect Ther; 2015; 13(12):1433-40. PubMed ID: 26559086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]